ZA921091B - Substituted benzofuranylpiperidine as a nootropic agent - Google Patents

Substituted benzofuranylpiperidine as a nootropic agent

Info

Publication number
ZA921091B
ZA921091B ZA921091A ZA921091A ZA921091B ZA 921091 B ZA921091 B ZA 921091B ZA 921091 A ZA921091 A ZA 921091A ZA 921091 A ZA921091 A ZA 921091A ZA 921091 B ZA921091 B ZA 921091B
Authority
ZA
South Africa
Prior art keywords
benzofuranylpiperidine
substituted
nootropic agent
treatment
nootropic
Prior art date
Application number
ZA921091A
Other languages
English (en)
Inventor
Cesare Mondadori
Mondadori Cesare
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of ZA921091B publication Critical patent/ZA921091B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
ZA921091A 1991-02-15 1992-02-14 Substituted benzofuranylpiperidine as a nootropic agent ZA921091B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH47091 1991-02-15

Publications (1)

Publication Number Publication Date
ZA921091B true ZA921091B (en) 1992-09-30

Family

ID=4187740

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA921091A ZA921091B (en) 1991-02-15 1992-02-14 Substituted benzofuranylpiperidine as a nootropic agent

Country Status (16)

Country Link
EP (1) EP0499586B1 (da)
JP (1) JPH0570352A (da)
KR (1) KR920016098A (da)
AT (1) ATE138805T1 (da)
AU (1) AU655227B2 (da)
CA (1) CA2061015A1 (da)
DE (1) DE59206442D1 (da)
DK (1) DK0499586T3 (da)
ES (1) ES2087497T3 (da)
GR (1) GR3020155T3 (da)
IE (1) IE74906B1 (da)
IL (1) IL100889A (da)
MX (1) MX9200620A (da)
NO (1) NO179358C (da)
NZ (1) NZ241608A (da)
ZA (1) ZA921091B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3595093A (en) * 1992-02-21 1993-09-13 Ciba-Geigy Ag Brofaromine as an agent for treating social phobia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0386117B1 (en) * 1987-10-22 1999-01-07 Massachusetts Institute Of Technology Treating premenstrual or late luteal phase syndrome

Also Published As

Publication number Publication date
CA2061015A1 (en) 1992-08-16
IL100889A0 (en) 1992-11-15
IE920486A1 (en) 1992-08-26
GR3020155T3 (en) 1996-09-30
DE59206442D1 (de) 1996-07-11
IL100889A (en) 1997-03-18
ATE138805T1 (de) 1996-06-15
ES2087497T3 (es) 1996-07-16
EP0499586A1 (de) 1992-08-19
MX9200620A (es) 1992-08-01
NO920591D0 (no) 1992-02-14
KR920016098A (ko) 1992-09-24
NZ241608A (en) 1997-06-24
EP0499586B1 (de) 1996-06-05
NO179358B (no) 1996-06-17
NO920591L (no) 1992-08-17
JPH0570352A (ja) 1993-03-23
DK0499586T3 (da) 1996-06-24
AU1087792A (en) 1992-08-20
NO179358C (no) 1996-09-25
IE74906B1 (en) 1997-08-13
AU655227B2 (en) 1994-12-08

Similar Documents

Publication Publication Date Title
GR3031492T3 (en) 1,4-Disubstituted piperazines for the treatment of disorders of the central nervous system and neuro-endocrine disorders
NO931056D0 (no) Sulfonamido- og sulfonamidokarbonyl-pyridin-2-karboksylsyreamider samt deres pyridin-n-oksider, fremgangsmaater for fremstilling derav og anvendelse av forbindelsene som legemidler
ES8705387A1 (es) Un procedimiento para preparar derivados de n-aril-n-(4-piperidinil)-alcoxialquilamida
CA2107552A1 (en) Use of deprenyl to maintain, prevent loss, or recover nerve cell function
IL113411A (en) Pharmaceutical composition for the treatment or prophylaxis of hyperglycaemias comprising moxonidine as active ingredient and process for the production of such composition
ZA949332B (en) Use of 1-{4-[4-aryl(or heteroaryl)-1-piperazinyl]-butyl}-1H-azole derivatives for the preparation of medicaments intended for the treatment of disorders of gastric secretion
IL100889A0 (en) Substituted benzofuranylpiperidine as a nootropic agent
ES2081834T3 (es) Pirrolidin-2-onas 4-metil y 4-etil sustituidas.
DK0388298T3 (da) Azetidinylsubstituerede derivater af pyridoncarboxylsyrer, deres fremstilling og anvendelse som lægemidler
GR3017599T3 (en) Thiochromane derivatives, process for their preparation and pharmaceutical compositions containing them.
EP0500953A4 (en) Antineoplastic effect potentiator and antineoplastic agent
HUT61469A (en) Process for producing pharmaceutical composition with nervous system effects
GR3020230T3 (en) Acylsulphonamido and sulphonamidopyridine-2-carboxylic acid esters, pyridine-n-oxides thereof, a process for their preparation and their use as medicaments
ES2001104A6 (es) Un procedimiento para la preparacion de nuevos derivados sustituidos del acido 1,4-dihidro-3,5-piridindicarboxilico.
GR3031360T3 (en) Composition based on ibuprofen, for oral usage
CA2153570A1 (en) Pharmaceutical composition for treating nicotine dependence